Track the 红日药业 stock price and the full management transaction log of the company, a listed equity based in China. Shares are quoted on CN CN, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 红日药业 has logged 17 insider filings. Market capitalisation: €10.6bn. The latest transaction was reported on 23 May 2023 (Sale). Among the most active insiders: 姚小青. The full history is openly available.
17
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
17 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 16,494 of 25,821 companies
43.2
score / 100
Value
42
Quality
45
FCF yld7.1%
Earn yld0.2%
EV/EBITDA22.8x
ROE0.3%
Gross mgn53%
Net mgn0.4%
Debt/EBITDA1.9x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.